Cahill Financial Advisors’s Bio-Techne TECH Stock Holding History

Cahill Financial Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-340	Closed	-$41K	–	713
2021 Q3	$41K	Buy	+340	New	+$41.4K	0.01%	363

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Cahill Financial Advisors's TECH Position: Q4 2021 in Review

Cahill Financial Advisors sold out of Bio-Techne (TECH) in Q4 2021, closing a stake of 340 shares — an estimated $41K sold.

Cahill Financial Advisors first reported a position in TECH in Q3 2021 and held it in 1 quarter. The position peaked at $41K in Q3 2021. 575 funds tracked by Wall St. Rank hold TECH as of Q4 2021.

Cahill Financial Advisors reported no remaining Bio-Techne position as of Q4 2021 after selling out during the quarter.
Cahill Financial Advisors sold 340 Bio-Techne shares in Q4 2021, an estimated $41K.
Cahill Financial Advisors first reported a position in Bio-Techne in Q3 2021 and held it in 1 quarter.
Cahill Financial Advisors's Bio-Techne position peaked at $41K in Q3 2021.
575 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.